SEC Form 4 · accession 0001104659-17-044733
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald W. Glazer
Director
Period of report
Jul 10, 2017
Accepted (ET)
Jul 12, 2017 · 9:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1,F2 | Jul 10, 2017 | S | 3,604 | $71.7119 | D | 7,206 | D | |
| American Depositary SharesF1,F3 | Jul 10, 2017 | S | 7,206 | $72.3633 | D | 0 | D | |
| Ordinary SharesF4 | Jul 11, 2017 | G | 175,682 | $0.00 | D | 4,565,794 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each American Depositary Share represents 13 ordinary shares.
- F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.00 to $71.97, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.11 to $72.60, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F4Bona fide gift of shares which is exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5.